AGP Executive Report
Last update: 7 hours agoHemp Policy: Michigan businesses are cutting back as a federal hemp-THC ban nears, while the FDA is nine months late with hemp rules, adding uncertainty for the CBD market. Medical Use: A study of 8,353 chronic-pain patients found those receiving medical cannabis were two to three times more likely to stop long-term opioid prescriptions, especially at lower starting doses. Cancer Care: In a survey of 237 cancer patients, most recent cannabis users reported improvement in their main symptom and overall quality of life; researchers say patients want open conversations with clinicians. Health Risks: New studies flag potential harms, linking cannabis use to higher odds of stroke, while reports also associate prenatal cannabis use disorder with postpartum psychiatric emergencies and cannabis with many substance-related emergency visits among young people. Industry: Canadian cannabinoid-medicine maker MediPharm Labs launched an authorized cannabis extract oil in Brazil, extending its international reach.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
